This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw JSON (canonical form + also see JSON Format Specification)
Definition for Code SystemProductContactType
{ "resourceType" : "CodeSystem", "id" : "medicinal-product-contact-type", "meta" : { "lastUpdated" : "2024-12-04T09:56:58.036+11:00", "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"] }, "text" : { "status" : "generated", "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem medicinal-product-contact-type</b></p><a name=\"medicinal-product-contact-type\"> </a><a name=\"hcmedicinal-product-contact-type\"> </a><a name=\"medicinal-product-contact-type-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Last updated: 2021-01-05T10:01:24.148+11:00</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"shareablecodesystem.html\">Shareable CodeSystem</a></p></div><p>This case-sensitive code system <code>http://hl7.org/fhir/medicinal-product-contact-type</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">ProposedMAH<a name=\"medicinal-product-contact-type-ProposedMAH\"> </a></td><td>Proposed Marketing Authorization Holder/Person</td><td>Proposed Marketing Authorization Holder/Person</td></tr><tr><td style=\"white-space:nowrap\">ProcedureContactDuring<a name=\"medicinal-product-contact-type-ProcedureContactDuring\"> </a></td><td>Person/Company authorised for Communication during procedure</td><td>Person/Company authorised for Communication on behalf of the Applicant during the Procedure</td></tr><tr><td style=\"white-space:nowrap\">ProcedureContactAfter<a name=\"medicinal-product-contact-type-ProcedureContactAfter\"> </a></td><td>Person/Company authorised for Communication after procedure</td><td>Person/Company authorised for Communication between MAH and Authorities after Authorization</td></tr><tr><td style=\"white-space:nowrap\">QPPV<a name=\"medicinal-product-contact-type-QPPV\"> </a></td><td>Qualified Person Responsible for Pharmacovigilance</td><td>Qualified Person Responsible for Pharmacovigilance</td></tr><tr><td style=\"white-space:nowrap\">PVEnquiries<a name=\"medicinal-product-contact-type-PVEnquiries\"> </a></td><td>Pharmacovigilance Enquiry Information</td><td>Pharmacovigilance Enquiry Information</td></tr></table></div>" }, "extension" : [{ "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode" : "brr" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status", "valueCode" : "trial-use" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger" : 1 }], "url" : "http://hl7.org/fhir/medicinal-product-contact-type", "identifier" : [{ "system" : "urn:ietf:rfc:3986", "value" : "urn:oid:2.16.840.1.113883.4.642.4.1925" }], "version" : "6.0.0-ballot2", "name" : "ProductContactType", "title" : "Product Contact Type", "status" : "active", "experimental" : false, "date" : "2021-01-05T10:01:24+11:00", "publisher" : "HL7 (FHIR Project)", "contact" : [{ "telecom" : [{ "system" : "url", "value" : "http://hl7.org/fhir" }, { "system" : "email", "value" : "fhir@lists.hl7.org" }] }], "description" : "Contact type for a Medicinal Product.", "jurisdiction" : [{ "coding" : [{ "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm", "code" : "001", "display" : "World" }] }], "caseSensitive" : true, "valueSet" : "http://hl7.org/fhir/ValueSet/medicinal-product-contact-type", "content" : "complete", "concept" : [{ "code" : "ProposedMAH", "display" : "Proposed Marketing Authorization Holder/Person", "definition" : "Proposed Marketing Authorization Holder/Person" }, { "code" : "ProcedureContactDuring", "display" : "Person/Company authorised for Communication during procedure", "definition" : "Person/Company authorised for Communication on behalf of the Applicant during the Procedure" }, { "code" : "ProcedureContactAfter", "display" : "Person/Company authorised for Communication after procedure", "definition" : "Person/Company authorised for Communication between MAH and Authorities after Authorization" }, { "code" : "QPPV", "display" : "Qualified Person Responsible for Pharmacovigilance", "definition" : "Qualified Person Responsible for Pharmacovigilance" }, { "code" : "PVEnquiries", "display" : "Pharmacovigilance Enquiry Information", "definition" : "Pharmacovigilance Enquiry Information" }] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.core#6.0.0-ballot2 generated on Tue, Dec 3, 2024 23:24+0000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R5 |
|
Propose a change